TFX (Teleflex) Research & Development: $153 Mil (TTM As of Mar. 2026)


TFX Teleflex Inc TFX
76 GF Score
Price $127.79
GF Value $179.56
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Teleflex Research & Development?

Teleflex TFX +1.01% 76 Research & Development is $153 Mil as of Mar. 2026. GuruFocus rates TFX with a GF Score™ of 76/100 and a GF Value™ of $179.56 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Teleflex's Research & Development for the three months ended in Mar. 2026 was $44 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $153 Mil.

Teleflex  (NYSE:TFX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Teleflex Research & Development Related Terms

Teleflex Research & Development Historical Data

* Premium members only.

The historical data trend for Teleflex's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex Research & Development Chart

Teleflex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 130.84 153.82 113.63 109.02 144.78

Teleflex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.30 38.52 57.23 12.63 44.39
TFX
76GF Score
Teleflex Inc TFX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teleflex Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $153 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $153 Mil mean?
Teleflex (TFX) has a Research & Development of $153 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Teleflex and its competitors.
Is Teleflex's Research & Development too high?
Teleflex's current Research & Development is $153 Mil. Overall, Teleflex has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teleflex's Research & Development compare to AVTR and STVN?
Teleflex's Research & Development of $153 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Teleflex and its competitors. Teleflex's current Research & Development is $153 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teleflex stock overvalued right now?
Based on GuruFocus' analysis, Teleflex (TFX) is currently considered Modestly Undervalued. The stock's GF Value™ is $179.56, compared to a current price of $127.79 — trading 28.8% below its estimated fair value. The current Research & Development is $153 Mil. Teleflex's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Teleflex (TFX), the current Research & Development is $153 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teleflex (TFX) Overvalued in 2026?

Based on GuruFocus' analysis, Teleflex stock appears to be undervalued. The current stock price of $127.79 is trading 28.8% below its estimated GF Value™ of $179.56. GuruFocus considers Teleflex to be Modestly Undervalued.

Key valuation signals for TFX:

  • Research & Development: $153 Mil
  • GF Value™: $179.56 vs. price of $127.79 (28.8% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the TFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teleflex Business Description

Other Exchanges 1TFX:ItalyTBH:Germany
Address 550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
76GF Score

Get the complete analysis for TFX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$127.79
Price
$179.56
GF Value